PartsTable
Technical Data Sheet
NDC00019-5505-06 ✓ Verified by PartsTable
· COMPONENT
WHAT YOU NEED TO KNOW
Verify manufacturer and server generation compatibility Check if Option PN or Spare PN — same part, different channel
Confirm exact part number — similar PNs may be different parts
PRODUCT OVERVIEW

IOXAGLATE MEGLUMINE AND IOXAGLAT. Key specifications include primary_container_type: VIAL, SINGLE DOSE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 25, primary_container_content_quantity: 50.000 MILLILITERS, part_name_assigned_by_controlling_agency: IOXAGLATE MEGLUMINE AND IOXAGLATE SODIUM USP 50ML VIAL 25S. This product is currently in active production with full OEM support.

This part is cataloged in the Federal Logistics Information System (FLIS) under NSN 6505-01-262-2300, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS
NDC00019-5505-06
NSN: 6505-01-262-2300
FSC: 6505
CAGE: 62910 — MALLINCKRODT SPECIALTY CHEMICALS CO (USA)
SPECIFICATIONS
primary_container_typeVIAL, SINGLE DOSE
medical_designation_and_gradeUNITED STATES PHARMACOPEIA
total_primary_container_quantity25
primary_container_content_quantity50.000 MILLILITERS
active_medicament_medicinal_strength39.300 PERCENTAGE, W/V IOXAGLATE MEGLUMINE ACTIVE INGREDIENT AND 19.600 PERCENTAGE, W/V IOXAGLATE SODIUM ACTIVE INGREDIENT
part_name_assigned_by_controlling_agencyIOXAGLATE MEGLUMINE AND IOXAGLATE SODIUM USP 50ML VIAL 25S
NSN6505-01-262-2300
COMPONENT DIAGRAM
COMPONENT MAIN IC EDGE CONNECTOR No detailed specs available IOXAGLATE MEGLUMINE AND IOXAGLAT TITLE COMPONENT PN NDC00019-5505-06 MFR IOXAGLATE MEGLUMINE AN
KEY FEATURES
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 39.300 PERCENTAGE, W/V IOXAGLATE MEGLUMINE ACTIVE INGREDIENT AND 19.600 PERCENTAGE, W/V IOXAGLATE SODIUM ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 25
MEDICAL DESIGNATION AND GRADE: UNITED STATES PHARMACOPEIA
TECHNICAL CHARACTERISTICS (FLIS)
PART NAME ASSIGNED BY CONTROLLING AGENCYIOXAGLATE MEGLUMINE AND IOXAGLATE SODIUM USP 50ML VIAL 25S
PRIMARY CONTAINER CONTENT QUANTITY50.000 MILLILITERS
ACTIVE MEDICAMENT MEDICINAL STRENGTH39.300 PERCENTAGE, W/V IOXAGLATE MEGLUMINE ACTIVE INGREDIENT AND 19.600 PERCENTAGE, W/V IOXAGLATE SODIUM ACTIVE INGREDIENT
PRIMARY CONTAINER TYPEVIAL, SINGLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY25
MEDICAL DESIGNATION AND GRADEUNITED STATES PHARMACOPEIA
VERIFIED SUBSTITUTES & CROSS-REFERENCES 8
HEXABRIXInterchangeable
interchangeable cross-reference
interchangeable
A89D103Interchangeable
interchangeable cross-reference
interchangeable
NDC00019-5505-10Interchangeable
interchangeable cross-reference
interchangeable
5505-101Interchangeable
interchangeable cross-reference
interchangeable
5505-21Interchangeable
interchangeable cross-reference
interchangeable
NDC00019-5505-21Interchangeable
interchangeable cross-reference
interchangeable
LIFECYCLE
StatusACTIVE
AvailabilityOEM and secondary market
RoHS CompliantEAR99Not HAZMAT
Ready to buy NDC00019-5505-06?
Compare prices from verified sellers on eBay
Buy on eBay →
As an eBay Partner, PartsTable may earn a commission. Your price is not affected.
FREQUENTLY ASKED QUESTIONS
What is NDC00019-5505-06?
NDC00019-5505-06 is a IOXAGLATE MEGLUMINE AND IOXAGLAT.
What parts can replace NDC00019-5505-06?
There are 8 known substitutes for NDC00019-5505-06: HEXABRIX, A89D103, NDC00019-5505-10 and 5 more. Substitute compatibility should be verified for your specific system.
What is the NSN for NDC00019-5505-06?
NDC00019-5505-06 is cataloged in the Federal Logistics Information System (FLIS) under NSN 6505-01-262-2300. This indicates validated use in U.S. government and defense supply chains.
Community Feedback
Comments (0)
No comments yet. Be the first to share what you know.
Leave a Comment
Comments are reviewed before appearing. You will receive an email to verify before your comment appears.

Request a Quote — NDC00019-5505-06